Concourse Financial Group Securities, Inc. Biofrontera Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.56 Billion
  • Q2 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$0.4 - $0.65 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.56 - $1.02 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.77 - $24.8 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.82 - $41.8 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$37.2 - $99.2 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$45.0 - $138.4 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$49.4 - $263.4 $0 - $0
0 New
0 $0

About Biofrontera Inc.

BFRI Quotes by TradingView
  • Ticker BFRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 23,551,000
  • Market Cap $30.1M
  • Description
  • Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...
More about BFRI
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email